{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T14:07:52Z","timestamp":1769782072296,"version":"3.49.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.cellsig.2025.111811","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T17:41:34Z","timestamp":1744652494000},"page":"111811","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["MAD2L1-mediated NANOG nuclear translocation: A critical factor in lung cancer chemoresistance"],"prefix":"10.1016","volume":"132","author":[{"given":"Hongye","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongcun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingge","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yishuai","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7689","key":"10.1016\/j.cellsig.2025.111811_bb0005","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature25183","article-title":"The biology and management of non-small cell lung cancer","volume":"553","author":"Herbst","year":"2018","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.cellsig.2025.111811_bb0010","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1470-2045(20)30641-0","article-title":"First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial","volume":"22","author":"Paz-Ares","year":"2021","journal-title":"Lancet Oncol."},{"issue":"10","key":"10.1016\/j.cellsig.2025.111811_bb0015","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.37699","article-title":"Comparison of carboplatin with cisplatin in small cell lung cancer in US veterans","volume":"5","author":"Azar","year":"2022","journal-title":"JAMA Netw. Open"},{"issue":"6","key":"10.1016\/j.cellsig.2025.111811_bb0020","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1586\/14737140.2016.1170596","article-title":"Platinum-based chemotherapy in advanced non-small-cell lung cancer: optimal number of treatment cycles","volume":"16","author":"Rossi","year":"2016","journal-title":"Expert. Rev. Anticancer. Ther."},{"issue":"5","key":"10.1016\/j.cellsig.2025.111811_bb0025","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1158\/1078-0432.CCR-21-3194","article-title":"A randomized phase II study comparing nivolumab with carboplatin\u2013pemetrexed for EGFR-mutated NSCLC with resistance to EGFR tyrosine kinase inhibitors (WJOG8515L)","volume":"28","author":"Hayashi","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2025.111811_bb0030","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.pharmthera.2019.06.005","article-title":"Drug resistance in non-small cell lung Cancer (NSCLC): impact of genetic and non-genetic alterations on therapeutic regimen and responsiveness","volume":"202","author":"Terlizzi","year":"2019","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.cellsig.2025.111811_bb0035","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3390\/cancers14020267","article-title":"Impact of cancer stem cells and cancer stem cell-driven drug resiliency in lung tumor: options in sight","volume":"14","author":"Cortes-Dericks","year":"2022","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.cellsig.2025.111811_bb0040","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41417-022-00586-8","article-title":"MAD2L1 is transcriptionally regulated by TEAD4 and promotes cell proliferation and migration in colorectal cancer","volume":"30","author":"Li","year":"2023","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.cellsig.2025.111811_bb0045","doi-asserted-by":"crossref","first-page":"12123","DOI":"10.2147\/CMAR.S265779","article-title":"Bioinformatics analysis and validation identify CDK1 and MAD2L1 as prognostic markers of rhabdomyosarcoma","author":"Lu","year":"2020","journal-title":"Cancer Manag. Res."},{"issue":"4","key":"10.1016\/j.cellsig.2025.111811_bb0050","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/1098-2264(2000)9999:9999<::AID-GCC1044>3.0.CO;2-N","article-title":"Expression and mutational analyses of the human MAD2L1 gene in breast cancer cells","volume":"29","author":"Percy","year":"2000","journal-title":"Genes Chromosom. Cancer"},{"issue":"2","key":"10.1016\/j.cellsig.2025.111811_bb0055","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000032625","article-title":"Upregulation of MAD2L1 mediated by ncRNA axis is associated with poor prognosis and tumor immune infiltration in hepatocellular carcinoma: a review","volume":"102","author":"Liu","year":"2023","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111811_bb0060","doi-asserted-by":"crossref","first-page":"10075","DOI":"10.1038\/s41598-024-60967-x","article-title":"Exosomal miR-493 suppresses MAD2L1 and induces chemoresistance to intraperitoneal paclitaxel therapy in gastric cancer patients with peritoneal metastasis","volume":"14","author":"Makinoya","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellsig.2025.111811_bb0065","first-page":"1","article-title":"Identification of MAD2L1 and BUB1B as potential biomarkers associated with progression and prognosis of ovarian Cancer","author":"Tang","year":"2024","journal-title":"Biochem. Genet."},{"issue":"4","key":"10.1016\/j.cellsig.2025.111811_bb0070","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.gendis.2023.02.025","article-title":"Regulatory effects of miR-19a on MAD2 expression and tumorigenesis in gastric cancer","volume":"10","author":"Bargiela-Iparraguirre","year":"2023","journal-title":"Genes & Diseases"},{"issue":"8","key":"10.1016\/j.cellsig.2025.111811_bb0075","article-title":"Biological and clinical significance of MAD2L1 and BUB1, genes frequently appearing in expression signatures for breast cancer prognosis","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cellsig.2025.111811_bb0080","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fgene.2020.00045","article-title":"Identification of core gene expression signature and key pathways in colorectal cancer","volume":"11","author":"Ding","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.cellsig.2025.111811_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2022.146448","article-title":"Nanog, as a key cancer stem cell marker in tumor progression","volume":"827","author":"Vasefifar","year":"2022","journal-title":"Gene"},{"issue":"23","key":"10.1016\/j.cellsig.2025.111811_bb0090","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.2217\/epi-2021-0228","article-title":"The multiple faces of NANOG in cancer: a therapeutic target to chemosensitize therapy-resistant cancers","volume":"13","author":"Fatma","year":"2021","journal-title":"Epigenomics"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111811_bb0095","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41389-020-00300-z","article-title":"PI3K\/Akt pathway and Nanog maintain cancer stem cells in sarcomas","volume":"10","author":"Yoon","year":"2021","journal-title":"Oncogenesis"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111811_bb0100","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41467-023-35856-y","article-title":"Niche stiffness sustains cancer stemness via TAZ and NANOG phase separation","volume":"14","author":"Liu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellsig.2025.111811_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.153869","article-title":"Nanog suppression enhanced the chemosensitivity of human non-small-cell lung cancer cells to cisplatin and inhibited cell migration","volume":"233","author":"Najafzadeh","year":"2022","journal-title":"Pathol.-Res. Pract."},{"key":"10.1016\/j.cellsig.2025.111811_bb0110","first-page":"1","article-title":"Bioinformatic analysis revealing mitotic spindle assembly regulated NDC80 and MAD2L1 as prognostic biomarkers in non-small cell lung cancer development","volume":"13","author":"Wei","year":"2020","journal-title":"BMC Med. Genet."},{"issue":"9","key":"10.1016\/j.cellsig.2025.111811_bb0115","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/jmg.2009.074252","article-title":"Functional evaluation of missense variations in the human MAD1L1 and MAD2L1 genes and their impact on susceptibility to lung cancer","volume":"47","author":"Guo","year":"2010","journal-title":"J. Med. Genet."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111811_bb0120","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41392-022-01080-1","article-title":"Hypoxia signaling in human health and diseases: implications and prospects for therapeutics","volume":"7","author":"Luo","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cellsig.2025.111811_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-020-01824-3","article-title":"Hypoxia, endoplasmic reticulum stress and chemoresistance: dangerous liaisons","volume":"40","author":"Akman","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.cellsig.2025.111811_bb0130","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1158\/0008-5472.CAN-22-2045","article-title":"Enhanced glutaminolysis drives hypoxia-induced chemoresistance in pancreatic cancer","volume":"83","author":"Park","year":"2023","journal-title":"Cancer Res."},{"issue":"36","key":"10.1016\/j.cellsig.2025.111811_bb0135","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1038\/s41388-021-01960-w","article-title":"Hypoxic exosomal HIF-1\u03b1-stabilizing circZNF91 promotes chemoresistance of normoxic pancreatic cancer cells via enhancing glycolysis","volume":"40","author":"Zeng","year":"2021","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.cellsig.2025.111811_bb0140","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3390\/cells11040632","article-title":"Drug resistance and endoplasmic reticulum stress in hepatocellular carcinoma","volume":"11","author":"Khaled","year":"2022","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.cellsig.2025.111811_bb0145","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/s41419-021-04251-0","article-title":"Downregulation of PHLPP induced by endoplasmic reticulum stress promotes eIF2\u03b1 phosphorylation and chemoresistance in colon cancer","volume":"12","author":"Guo","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellsig.2025.111811_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-020-02587-3","article-title":"Identification of cancer stem cell-related biomarkers in intestinal-type and diffuse-type gastric cancer by stemness index and weighted correlation network analysis","volume":"18","author":"Guo","year":"2020","journal-title":"J. Transl. Med."},{"issue":"6","key":"10.1016\/j.cellsig.2025.111811_bb0155","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.3390\/genes14061276","article-title":"Suppression of NANOG expression reduces drug resistance of cancer stem cells in glioblastoma","volume":"14","author":"Smith","year":"2023","journal-title":"Genes"},{"issue":"21","key":"10.1016\/j.cellsig.2025.111811_bb0160","doi-asserted-by":"crossref","first-page":"9601","DOI":"10.7150\/thno.49270","article-title":"Targeting MAD2 modulates stemness and tumorigenesis in human gastric Cancer cell lines","volume":"10","author":"Pajuelo-Lozano","year":"2020","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.cellsig.2025.111811_bb0165","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/1440-1681.13287","article-title":"The combination of artesunate and carboplatin exerts a synergistic anti-tumour effect on non-small cell lung cancer","volume":"47","author":"Wang","year":"2020","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111811_bb0170","first-page":"25","article-title":"Isorhamnetin flavonoid synergistically enhances the anticancer activity and apoptosis induction by cis-platin and carboplatin in non-small cell lung carcinoma (NSCLC)","volume":"8","author":"Zhang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"51","key":"10.1016\/j.cellsig.2025.111811_bb0175","doi-asserted-by":"crossref","first-page":"85235","DOI":"10.18632\/oncotarget.13252","article-title":"Prognostic and predictive values of CDK1 and MAD2L1 in lung adenocarcinoma","volume":"7","author":"Shi","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111811_bb0180","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12894-022-00991-z","article-title":"Single-cell sequencing reveals MYC targeting gene MAD2L1 is associated with prostate cancer bone metastasis tumor dormancy","volume":"22","author":"Wang","year":"2022","journal-title":"BMC Urol."},{"issue":"5","key":"10.1016\/j.cellsig.2025.111811_bb0185","doi-asserted-by":"crossref","first-page":"1903035","DOI":"10.1002\/advs.201903035","article-title":"Methylation status of the nanog promoter determines the switch between cancer cells and cancer stem cells","volume":"7","author":"Liu","year":"2020","journal-title":"Adv. Sci."},{"issue":"7","key":"10.1016\/j.cellsig.2025.111811_bb0190","doi-asserted-by":"crossref","first-page":"6260","DOI":"10.3390\/ijms24076260","article-title":"TRRAP enhances cancer stem cell characteristics by regulating NANOG protein stability in colon cancer cells","volume":"24","author":"Kang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.cellsig.2025.111811_bb0195","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ijc.33544","article-title":"Nanog is a promising chemoresistant stemness marker and therapeutic target by iron chelators for esophageal cancer","volume":"149","author":"Narusaka","year":"2021","journal-title":"Int. J. Cancer"},{"issue":"11","key":"10.1016\/j.cellsig.2025.111811_bb0200","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/s41568-023-00612-3","article-title":"Advances in the structure, mechanism and targeting of chemoresistance-linked ABC transporters","volume":"23","author":"Sajid","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111811_bb0205","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1038\/s41467-021-23071-6","article-title":"Mitochondrial ATP fuels ABC transporter-mediated drug efflux in cancer chemoresistance","volume":"12","author":"Giddings","year":"2021","journal-title":"Nat. Commun."},{"issue":"31","key":"10.1016\/j.cellsig.2025.111811_bb0210","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.2217\/fon-2021-0172","article-title":"An insight into the cancer stem cell survival pathways involved in chemoresistance in triple-negative breast cancer","volume":"17","author":"Qayoom","year":"2021","journal-title":"Future Oncol."},{"issue":"20","key":"10.1016\/j.cellsig.2025.111811_bb0215","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1158\/0008-5472.CAN-20-0378","article-title":"Slow-cycling cancer stem cells regulate progression and chemoresistance in colon cancer","volume":"80","author":"Shiokawa","year":"2020","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.cellsig.2025.111811_bb0220","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1200\/JCO.21.01845","article-title":"Managing resistance to immune checkpoint inhibitors in lung cancer: treatment and novel strategies","volume":"40","author":"Passaro","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.cellsig.2025.111811_bb0225","first-page":"377","article-title":"Overcoming therapy resistance in EGFR-mutant lung cancer","volume":"2","author":"Passaro","year":"2021","journal-title":"Nat. Can."},{"issue":"11","key":"10.1016\/j.cellsig.2025.111811_bb0230","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1158\/1078-0432.CCR-19-3906","article-title":"MET alterations are a recurring and actionable resistance mechanism in ALK-positive lung cancer","volume":"26","author":"Dagogo-Jack","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.cellsig.2025.111811_bb0235","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.annonc.2020.09.015","article-title":"Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer","volume":"31","author":"Lin","year":"2020","journal-title":"Ann. Oncol."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825002244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825002244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T12:20:16Z","timestamp":1769689216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656825002244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":47,"alternative-id":["S0898656825002244"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.111811","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MAD2L1-mediated NANOG nuclear translocation: A critical factor in lung cancer chemoresistance","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.111811","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111811"}}